About FDA
Cumulative percentage of required workplace inspection completed within the FY
Cumulative FY 2011 Target: 100% of 530 inspections by 9/30/2011
Dictionary: RCRM employees perform periodic ESH surveys and audits to identify deficiencies and implement corrective procedures or abatement actions. RCRM also inspects and monitors building ventilation and exhaust systems, and makes recommendations, where necessary, to decrease the possibility of workplace air contamination. Additionally, RCRM inspects and provides recommendations for any other safety compliance issues.
Safety and Environmental Compliance inspections help to not only make the FDA employees safe, but also allow for research to be conducted in a safe environment.
Fiscal Year - 2011
Cumulative FY 2011 Target: 100% of 530 inspections by 9/30/2011
| Time | Target | Cumulative Percent |
|---|---|---|
| Oct 2010 | N/A | 5 |
| Nov 2010 | N/A | 7 |
| Dec 2010 | N/A | 15 |
| Jan 2011 | N/A | 17 |
| Feb 2011 | N/A | 20 |
| Mar 2011 | N/A | 28 |
| Apr 2011 | N/A | 31 |
| May 2011 | N/A | 36 |
| Jun 2011 | N/A | 44 |
| Jul 2011 | N/A | 46 |
| Aug 2011 | N/A | 50 |
| Sep 2011 | N/A | 75 |
FY 2011 Overall: 75%
Cumulative number of workplace inspections conducted within the FY
Fiscal Year - 2011
| Time | Cumulative Monthly Target | Cumulative Number |
|---|---|---|
| Oct 2010 | 44 | 25 |
| Nov 2010 | 88 | 35 |
| Dec 2010 | 132 | 79 |
| Jan 2011 | 176 | 93 |
| Feb 2011 | 220 | 105 |
| Mar 2011 | 265 | 149 |
| Apr 2011 | 308 | 162 |
| May 2011 | 352 | 189 |
| Jun 2011 | 396 | 232 |
| Jul 2011 | 440 | 245 |
| Aug 2011 | 484 | 266 |
| Sep 2011 | 528 | 400 |
FY 2011 Total: 400
Glossary
ESH
Environmental, Safety, and Health
Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.







